Articles tagged with Cardiology
The September issue of the CHEST journal features research on long COVID, including a review on exercise pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2. Original studies also explore asthma treatment with albuterol-budesonide inhalers and sleep therapy using oronasal masks.
Researchers analyzed data from 2005-2020 and found that 10-year conditional survival was similar between biventricular and most single-ventricle CHD patients. Biventricular CHD patients also showed better 10-year survival compared to non-CHD heart transplant recipients.
A study from Amsterdam UMC followed over 250 elite athletes who had contracted COVID-19 and found no severe heart issues impacting their careers. Despite some athletes showing slightly elevated resting heart rates, there were no significant differences in overall heart function or ventricular arrhythmias.
Research published in the Journal of the American Heart Association found that patients who start taking a combination of statins and ezetimibe after a heart attack are 47% less likely to die within three years. The study suggests that changing treatment guidelines could prevent many thousands of deaths each year.
A novel study published in The Lancet finds that redo TAVR with balloon-expandable valves is both safe and effective for select patients who require a repeat procedure. The study, led by Cedars-Sinai, showed no difference in death or stroke rates between redo and first-time TAVR at 30-day and one-year marks.
A recent clinical trial led by Professor Holger Thiele found that ECLS does not reduce 30-day mortality after cardiogenic shock, but is associated with more complications. The study involved 420 patients and compared ECLS therapy with standard intensive care unit treatment.
A study by the British Heart Foundation found that in England and Scotland, the average distance to a 24/7 accessible defibrillator is over 1.8km in deprived areas, highlighting alarming health inequalities. Researchers are urging urgent action to improve access to these lifesaving devices.
The Cardiovascular Research Foundation has announced the TCT 2023 late-breaking clinical trials, featuring 12 studies on minimally invasive techniques, pharmaceuticals, technologies, and devices. These trials aim to improve patient outcomes in cardiovascular disease, with a focus on safety and effectiveness.
Researchers found that optimized statin therapy can significantly reduce mortality and cardiovascular events in US military veterans with coronary artery disease. Widespread use of ezetimibe alongside statins may lead to additional reductions in cardiovascular risk.
Patients with valvular heart disease, congenital abnormalities, or pacemakers should prioritize prevention measures like twice-daily tooth cleaning and strict skin hygiene. The Guidelines emphasize the importance of patient education, antibiotic prophylaxis, and early diagnosis to combat infective endocarditis.
A new study found that younger atrial fibrillation (AFib) patients who underwent MRI-guided ablation treatments had better outcomes. The treatment significantly improved arrhythmia recurrence rates by 50% for patients under 58 years old.
The European Society of Cardiology calls for competency-based cardiac imaging delivery to enhance effective and efficient patient care. This approach enables cardiologists to deliver high-quality imaging services, select the most appropriate modality for each clinical scenario, and provide informed decision-making.
The COVID-19 pandemic worsened treatment outcomes for patients admitted with acute myocardial infarction (AMI), but did not significantly amplify existing racial and ethnic disparities in care. Additional efforts are needed to mitigate these inequities, particularly during periods of high hospital COVID-19 burden.
The Texas Heart Institute has received a five-year, $2 million grant from the National Institutes of Health to advance organ bioengineering. The project aims to develop transplantable bioartificial hearts to combat end-stage heart failure.
Fish oil supplements often make health claims without sufficient trial data, leading to potential variability in safety and efficacy due to differing doses of eicosapentaenoic acid and docosahexaenoic acid. The study highlights the need for more rigorous regulation of these products.
A new study found that catheter ablation significantly lowers the incidence of cardiovascular events and death in very old patients with nonvalvular atrial fibrillation. The researchers compared 208 patients who underwent AF ablation with those who received medical therapy only, finding a lower risk of both cardiovascular events and de...
Researchers at Brigham and Women's Hospital have developed an AI model that screens electrocardiograms (ECG) for signs of atrial septal defects (ASD), a common adult congenital heart disease. The model correctly detected ASD in 93.7% of cases, outperforming traditional methods.
A recent study at UC Irvine found that semaglutide medication can lead to significant weight loss and reduce cardiovascular risk in 93 million U.S. adults. The medication may prevent up to 1.5 million heart attacks and strokes over 10 years, resulting in 43 million fewer obese people.
The study found that walking at least 3967 steps a day reduces the risk of dying from any cause, while 2337 steps a day reduces the risk of dying from cardiovascular disease. The researchers also found that every 500-1000 extra steps increase health benefits and reduce mortality risk by up to 15%.
A new study reveals a high incidence of youth with cardiovascular risk factors but inadequate resources to provide preventive care. Pediatricians and policymakers must address these gaps by investing in pediatric preventive cardiology and increasing collaboration between programs.
A new American Heart Association science advisory emphasizes the need for more resources and best practices in pediatric preventive cardiovascular care. The survey found that many programs are overwhelmed with referrals and have long wait times, highlighting the importance of updated guidelines and strategic action plans.
Researchers found that African ancestry patients with dilated cardiomyopathy have fewer clinically actionable variants in DCM genes compared to European ancestry patients. The study enrolled 1,198 patients with dilated cardiomyopathy, revealing a racial imbalance in genetic trials for heart failure.
A study found that breast cancer patients with higher body mass index (BMI) are more likely to experience heart damage, or cardiotoxicity, during chemotherapy. The study suggests that addressing obesity and considering the potential risk of cardiotoxicity requires a comprehensive approach.
The conference will focus on optimizing patient care in the Latin America region, discussing strategies to improve heart health and address rising cardiovascular disease rates. Key topics include cardiac rehabilitation, heart failure management, and practical approaches for clinicians.
A Northwestern University study found that only 60% of women with heart disease risk factors received counseling on optimizing their heart health during their six-week postpartum visit. The study highlights the need for improved access to care and increased awareness of maternal cardiovascular health monitoring.
A study published in Science reveals that ganglia in the neck region are responsible for disrupting melatonin production and causing sleep disturbances in people with heart conditions. Researchers found that macrophages accumulate in the ganglion, leading to inflammation and scarring, which can be treated with drugs.
The American Heart Association and the American College of Cardiology recommend a heart-healthy diet and lifestyle to prevent worsening health in people with chronic coronary disease. Clinicians should coordinate care between cardiovascular and primary care professionals, emphasizing team-based approach and social determinants of health.
Massachusetts General Hospital researchers discovered that concentrating moderate-to-vigorous physical activity into one to two days per week, or the
A new study reveals that Black patients with ICDs have a significantly higher rate of post-implant cardiac events and risk of death compared to white patients. The study also shows that Black patients are more likely to discontinue medications after one year, but the reasons for this are unknown.
Researchers at NIST and their colleagues used machine learning to identify abnormal cardiac rhythms in firefighters, achieving 97% accuracy. The Heart Health Monitoring model could lead to a portable heart monitor to detect early warning signs of heart trouble and prevent fatal cardiac events.
A study published in the Journal of the American College of Cardiology found that alerting volunteers can increase bystander CPR and AED use, leading to improved survival rates. The volunteer system increased rates of CPR and defibrillation in out-of-hospital cardiac arrests, giving victims a higher chance of receiving early care.
Researchers developed an AI model that accurately classifies six types of valvular heart disease using chest radiographs, with high accuracy rates. The model's potential applications include supplementing echocardiography in areas where specialists are scarce and improving emergency care.
The SAFE-MCS study evaluates the safety of complex high-risk PCI using the Impella Heart Pump in conjunction with the Saranas Early Bird Bleed Monitoring System. The primary clinical endpoint is the incidence of access site-related Bleeding Academic Research Consortium (BARC) type III or V bleeding.
A new study reveals that biscuspid aortic valve is caused by mutations in the MINDBOMB1 gene, with significant implications for developing alternative treatments to surgery. The research combines genome sequencing and gene editing techniques to analyze the mechanisms of this congenital defect.
A large Swedish study found that higher cardiorespiratory fitness may lower the incidence and mortality rates of certain cancers in men. The researchers suggest prioritizing CRF interventions for individuals with low fitness levels.
The inaugural issue of CHEST Critical Care focuses on clinically relevant research and patient management guidance for critical care medicine. The journal accepts submissions of original research, case series, and research letters, covering topics such as intensive care medicine and diverse populations.
A new study published in JAMA found that bempedoic acid can reduce major adverse cardiovascular events in high-risk primary prevention patients who cannot tolerate recommended doses of statins. The treatment has the potential to improve outcomes for these patients, providing a new option for primary prevention.
A new analysis of the CLEAR Outcomes Trial found that bempedoic acid lowered LDL cholesterol levels by 21% and reduced cardiovascular events by 13%. This suggests that different classes of cholesterol drugs have similar benefits for cardiovascular health.
The TCT 2023 Program Guide features four days of innovation and cutting-edge science in interventional cardiovascular medicine. The event marks 35 years of leading the field and will gather top researchers and clinicians to present evidence-based research.
Chronic exposure to low levels of contaminant metals through household items, air, water, soil, and food increases the risk of cardiovascular disease. Monitoring environmental metal levels and testing for exposure are key steps to implement public health initiatives.
A study presented at the American College of Cardiology's Care of the Athletic Heart conference found that only 50% of athletes surveyed reported knowing what sudden cardiac arrest is or being concerned about it during play. The researchers identified 46 cases of sports-related cardiac arrests between 1984 and 2022 involving CPR, with ...
A new study found that most adults with Type 2 diabetes in Alabama Medicaid did not receive follow-up healthcare within the recommended two-week period after a heart failure hospitalization. African American and Hispanic adults were particularly affected, with worse follow-up care compared to white adults.
Researchers at Lund University have mapped the location where atherosclerotic plaques rupture, identifying an enzyme marker that could predict patients at risk of myocardial infarction or stroke. The study's findings may lead to preventive treatments and new therapies.
The British Junior Cardiologists' Association (BJCA) and the British Cardiovascular Society (BCS) have issued a joint policy statement to address bullying, harassment, and discrimination in UK cardiology departments. The statement emphasizes that every team member has a duty to call out inappropriate behaviors to drive culture change.
Research reveals that chronic heart rate failure during exercise is a common reason for long-term exercise intolerance in Long COVID patients. The study also found a correlation between early post-COVID inflammation biomarkers and reduced exercise capacity, suggesting potential therapeutic targets.
A new study confirms the safety and success of transcatheter edge-to-edge procedures for repairing leaky mitral valves. The minimally invasive procedure was shown to be successful in nearly nine out of ten patients, with strong safety and efficacy outcomes despite advanced age and comorbidities.
A new Northwestern University study finds that CT scans are more effective than genetics in predicting the risk of heart disease in middle-aged individuals. The study used data from over 3,200 adults and found that adding CT scan data to conventional risk factors improved the accuracy of risk prediction.
Njambi Mathenge has been selected as the recipient of the SCAI-WIN CHIP Fellowship, offering her additional year of advanced training focusing on complex and high-risk coronary intervention. She will pursue her fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital.
Dr. George Dangas has been appointed as the new President of SCAI, a non-profit professional association promoting excellence in interventional cardiovascular medicine. He is an authoritative voice on nonsurgical cardiovascular and valve interventions, and will fulfill various responsibilities including acting as spokesperson for SCAI.
SCAI has elected George D. Dangas, MD, MSCAI, as its new president, succeeding Suni V. Rao, MD, MSCAI. Dr. Dangas will lead the society in advancing interventional cardiology and promoting excellence in patient care.
A new device invented by Emile Daoud and his team at Ohio State University Wexner Medical Center significantly reduces the risk of esophageal injury during heart ablation. The device uses suction force to gently move the esophagus away from the catheter tip, creating a safe pathway for treatment.
The new guideline provides guidance on the use of cardiac resynchronization therapy and conduction system pacing in patients with indications for pacemakers or heart failure. The authors emphasize the importance of shared decision-making between providers and patients, and highlight areas for future research.
The Society for Cardiovascular Angiography and Interventions (SCAI) recognized outstanding interventionalists with the Master Interventionalists of SCAI (MSCAI) designation. The recipients demonstrated excellence in invasive/interventional cardiology, innovation, publication, and teaching.
The Society for Cardiovascular Angiography and Interventions (SCAI) has created a new recognition program, 30 in Their 30's, to celebrate the contributions of early-career interventional cardiologists. The award highlights leadership and demonstration of SCAI's core values.
The Society for Cardiovascular Angiography and Interventions (SCAI) has awarded Early Career Research Grants to two junior interventional cardiologists, Nadia Sutton and Eric Secemsky. Their projects focus on high-priority topics in cardiovascular disease, including coronary microvascular dysfunction and peripheral vascular interventions.
The next-generation Evolut FX TAVR system shows improved deliverability, tracking, and deployment compared to its predecessor. This is particularly beneficial for patients with difficult anatomies, where the new device's predictable deployment can improve coronary access, blood flow, and valve performance.
A study analyzing European guidelines found that patients with specific characteristics may benefit from longer-term treatment with multiple blood thinners. High-risk patients experienced higher rates of complications due to blood clotting, emphasizing the need for personalized care.
The Society for Cardiovascular Angiography & Interventions (SCAI) has released an expert consensus on the management of in-stent restenosis and stent thrombosis. The guidelines emphasize frequent use of intracoronary imaging to determine the precise etiology and guide selection of treatment options.
SCAI honored J. Dawn Abbott, MD, FSCAI and Douglas E. Drachman, MD, FSCAI with the Mason Sones Award for Distinguished Service for their efforts in education and quality of care. The Society also recognized Theodore A. Bass, MD, MSCAI, and Lee N. Benson, MD, MSCAI with lifetime service awards for their substantial contributions to SCAI.
A third-party analysis found that Impella support led to a greater extent of revascularization and lower heart failure and angina symptoms in patients undergoing high-risk percutaneous coronary intervention (PCI). The study showed a 40% greater reduction in residual SYNTAX Score post-PCI with Impella compared to IABP.